Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Xevant logo — Xevant leads the RxTech era, using AI to turn pharmacy data...

Xevant

Xevant leads the RxTech era, using AI to turn pharmacy data into action and deliver the lowest net cost.

Founded 2017 United States Lehi, United States 40 employees Venture round Total: $8.11M Health Care, Information Technology

General Information

Company Name Xevant
Founded Year 2017
Location United States Lehi, United States
Employees 40
Industries Health Care, Information Technology
Funding Stage Venture round
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Usage Based
Social

BounceWatch is an independent company data service, not affiliated with Xevant. To contact Xevant, visit xevant.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Xevant compare?

A PDF of Xevant and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Xevant soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Xevant

Xevant, founded in 2017, is at the forefront of the emerging RxTech era. The company specializes in using AI to transform complex pharmacy data into actionable insights that consistently deliver the lowest net pharmacy costs. Operating primarily in the Health Care and Information Technology sectors, Xevant is headquartered in the United States.

With its AI-driven platform, Xevant goes beyond traditional retrospective reporting to offer real-time orchestration of pharmacy benefits. This means continuously identifying opportunities for cost reduction and enhanced outcomes, far beyond mere data analysis. The company's proprietary technology, known as VerX, enables rapid and confident decision-making for plans, employers, and partners, ensuring compounding value over time.

Xevant last received a Venture Round investment on 21 February 2024, with investors such as Tech Council Ventures and HCAP Partners signaling strong market confidence in their innovative approach and leadership in the industry.

Business keywords: RxTech, Pharmacy Data Analytics, AI in Pharmacy, Pharmacy Benefits Optimization, Cost Reduction Strategies, Real-Time Data Orchestration, PBM Ecosystem Optimization, Intelligent Analytics Platform, Pharmacy Claims Data Analysis, Drug Pricing Analysis, Formulary Analytics, Drug Rebate Analytics, PBM Reporting Tools, Pharmacy Benefit Management, Healthcare Data Execution

Services & Products

VerX Operating System
AI-Driven Pharmacy Benefit Optimization
Real-time Claims and Cost Analysis
Rebate and Contract Management Solutions
Automated Disease and Utilization Management

Target Customers

Pharmacy Benefit Managers (PBMs) Third-Party Administrators (TPAs) Health Plans Consultants and Brokers Employers and Healthcare Payers

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 2
Tech Council Ventures
Tech Council Ventures, HCAP Partners
21 Feb 2024
Venture Round $5.00M -
03 Oct 2023
Private Equity Round Undisclosed 1
HCAP Partners
14 Mar 2023
Seed Round $3.11M -
29 Dec 2020

Xevant Alternatives & Competitors

View All Alternatives
Xevant vs
Benmedica
Benmedica United States

The Intelligent Multi-Channel ePrescribing Solution

Angel
6 employees
Consumer Electronics, Health Care
Xevant vs
SmithRx
SmithRx United States

Radically transparent pharmacy benefits.

Series C
409 employees
Health Care, Information Technology
Compare Xevant vs SmithRx
Xevant vs
Rescription
Rescription United States

Rescription replaces your PBM with a new delivery model that includes 100% of all prescription drugs...

19 employees
Data Analytics, Health Care
View all alternatives

FAQ About Xevant

Xevant leads the RxTech era, using AI to turn pharmacy data into action and deliver the lowest net cost.
Xevant was founded in 2017.
Xevant is headquartered in Lehi, United States.
Xevant operates in Health Care and Information Technology. Its work centres on RxTech, Pharmacy Data Analytics, AI in Pharmacy and Pharmacy Benefits Optimization. Its customers include Pharmacy Benefit Managers (PBMs), Third-Party Administrators (TPAs) and Health Plans.
Xevant has a B2B, SaaS and Platform business model. Its revenue comes from Subscription and Usage Based.
Xevant has approximately 40 employees.
Xevant has completed 4 funding rounds, raising a total of $8.11M. The latest funding stage is Venture round.
Xevant offers: VerX Operating System, AI-Driven Pharmacy Benefit Optimization, Real-time Claims and Cost Analysis, Rebate and Contract Management Solutions, Automated Disease and Utilization Management.
Top alternatives and competitors to Xevant include Benmedica, SmithRx, Rescription, Truveris, CenterX. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Xevant and Benmedica are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Xevant, https://bouncewatch.com/company/xevant, updated 23 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes